|
Dr. Carter joins Callisto after an extensive career in the area of cancer drug development and research as both a senior executive and director and as a medical researcher. Dr. Carter most recently served as Senior Vice President of Clinical and Regulatory Affairs for SUGEN Inc. a San Francisco-based biotechnology and pharmaceutical company now a subsidiary of Pfizer. Prior to SUGEN he held positions including Senior Vice President Research & Development for Boehringer Ingelheim Pharmaceuticals Inc. and Senior Vice President Woldwide Clinical Research & Development for Bristol-Myers Squibb Co.
Dr. Carter a former clinical professor of medicine at Stanford University and medical journal author received a medical degree from New York Medical College and a bachelor’s degree in American history from Columbia College. He is also a member of numerous cancer-related societies including the American Society of Clinical Oncology American Association for Cancer Research the Society for Surgical Oncology and the American Society of Pharmacology and Experimental Therapeutics. | 